0 NASDAQ Companies - January 14, 2019Microbot Medical Increases its Global IP Portfolio with Notice of Allowance from the European Patent OfficeHINGHAM, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) — Microbot Medical Inc. (NASDAQ: MBOT), received a notification from the European Patent […]Read More
0 NASDAQ Companies - January 14, 2019Nabriva Therapeutics Provides Update on PDUFA Date for Intravenous CONTEPO™-PDUFA action date now set for April 30, 2019- DUBLIN, Ireland, Jan. 14, 2019 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc […]Read More
0 NASDAQ Companies - January 14, 2019Scilex Announces Addition of ZTlido® to Express Scripts National FormulariesSAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) — Scilex Pharmaceuticals Inc. (SCILEX), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE), […]Read More
0 NASDAQ Companies - January 14, 2019Denny’s Corporation Releases Preliminary Financial Results for Fourth Quarter and Fiscal Year 2018– Company Reiterates 2018 Guidance Expectations for Adjusted EBITDA* – SPARTANBURG, S.C., Jan. 14, 2019 (GLOBE NEWSWIRE) — Denny’s Corporation […]Read More
0 NASDAQ Companies - January 14, 2019Valeritas Announces V-Go® Received Preferred Status on OptumRx FormulariesBRIDGEWATER, N.J., Jan. 14, 2019 (GLOBE NEWSWIRE) — Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of […]Read More
0 NASDAQ Companies - January 14, 2019BMC Announces Three New Additions to its Leadership TeamRALEIGH, N.C., Jan. 14, 2019 (GLOBE NEWSWIRE) — BMC Stock Holdings, Inc. (Nasdaq: BMCH) (“BMC” or the “Company”), a leading […]Read More
0 NASDAQ Companies - January 14, 2019iPic® Entertainment Announces Preliminary Fourth Quarter & Full Year 2018 Sales Results Above Previous Guidance RangesProvides Initial Outlook for Full Year 2019To Present at ICR Conference on January 15th BOCA RATON, Fla., Jan. 14, 2019 […]Read More
0 NASDAQ Companies - January 14, 2019Scilex Announces ZTlido® Insurance Coverage for ~100 Million Insured Lives(1)SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) — Scilex Pharmaceuticals Inc. (SCILEX), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE), […]Read More
0 NASDAQ Companies - January 14, 2019ReWalk Announces Preliminary Fiscal Year 2018 RevenueReStore clinical study accrual and follow up completed YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) — […]Read More
0 NASDAQ Companies - January 14, 2019Award of Restricted Stock UnitsSummit Therapeutics plc(“Summit Therapeutics” or the “Company”) Award of Restricted Stock Units Oxford, UK, and Cambridge, MA, US, 14 January […]Read More